Your browser is no longer supported. Please, upgrade your browser.
ENDP Endo International plc weekly Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-4.49 Insider Own0.50% Shs Outstand223.40M Perf Week4.12%
Market Cap2.20B Forward P/E3.62 EPS next Y2.72 Insider Trans-3.96% Shs Float201.62M Perf Month4.34%
Income-1004.10M PEG- EPS next Q0.60 Inst Own98.80% Short Float9.03% Perf Quarter-46.17%
Sales2.93B P/S0.75 EPS this Y60.70% Inst Trans0.12% Short Ratio4.42 Perf Half Y-12.13%
Book/sh-0.98 P/B- EPS next Y-0.51% ROA-10.10% Target Price16.61 Perf Year28.09%
Cash/sh5.01 P/C1.97 EPS next 5Y-8.47% ROE- 52W Range5.27 - 18.50 Perf YTD34.93%
Dividend- P/FCF7.76 EPS past 5Y1.10% ROI-9.10% 52W High-46.76% Beta1.10
Dividend %- Quick Ratio1.00 Sales past 5Y4.30% Gross Margin41.80% 52W Low86.91% ATR0.53
Employees3039 Current Ratio1.10 Sales Q/Q-5.30% Oper. Margin-20.30% RSI (14)54.92 Volatility3.84% 6.41%
OptionableYes Debt/Eq- EPS Q/Q-46.00% Profit Margin-37.80% Rel Volume1.02 Prev Close9.66
ShortableYes LT Debt/Eq- EarningsFeb 07 BMO Payout- Avg Volume4.12M Price9.85
Recom2.50 SMA2015.73% SMA50-10.53% SMA200-13.70% Volume4,257,008 Change1.97%
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $9 → $8
Sep-28-17Initiated Goldman Sell $7
Aug-09-17Reiterated RBC Capital Mkts Sector Perform $15 → $9
Jun-16-17Initiated Cantor Fitzgerald Neutral $12
Jun-09-17Downgrade Stifel Buy → Hold $22 → $15
May-25-17Reiterated Mizuho Buy $18 → $19
Feb-22-17Initiated Canaccord Genuity Hold $14
Jan-31-17Reiterated Mizuho Buy $25 → $15
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-08-19 11:34AM  Albany region cities sue pharmaceutical companies over opioid epidemic American City Business Journals
Jan-02-19 11:25AM  Government shutdown puts Endo-FDA lawsuit in limbo American City Business Journals +5.62%
06:58AM  Heron Gains on Priority Review Designation for Pain Drug Zacks
Dec-31-18 08:52AM  Options Traders Expect Huge Moves in Endo (ENDP) Stock Zacks
07:30AM  Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations PR Newswire
Dec-19-18 07:30AM  Endo to Participate at J.P. Morgan Healthcare Conference PR Newswire -5.11%
Dec-18-18 11:40AM  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets GlobeNewswire
Dec-16-18 07:10AM  Do Hedge Funds Love Endo International plc (ENDP)? Miller Value offer its opinion Insider Monkey
Dec-14-18 05:01PM  Endo International Drops Ahead Of '60 Minutes' Opioid Segment Benzinga -8.53%
03:55PM  Endo International plc (ENDP) Investigated For Violations of Federal Securities Laws by Block & Leviton LLP ACCESSWIRE
03:20PM  Endo International shares fall 8 percent on report of 'shocking' data on opioid distribution CNBC
Dec-12-18 07:54AM  FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller Reuters
Dec-11-18 09:23AM  Generic Drugmakers Down on Allegations of Price Fixing Zacks
Dec-08-18 09:30AM  Why Is Endo (ENDP) Down 12.3% Since Last Earnings Report? Zacks
Dec-05-18 02:17AM  Edited Transcript of ENDP earnings conference call or presentation 8-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Dec-04-18 08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Crocs, Ericsson, AAC, Coty, Tutor Perini, and Endo International plc New Research Emphasizes Economic Growth GlobeNewswire
Nov-28-18 04:34PM  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference PR Newswire
Nov-26-18 12:55PM  Endo to Participate at Piper Jaffray Global Healthcare Conference PR Newswire -7.75%
Nov-20-18 05:49PM  Bill Miller Sees a Buying Opportunity GuruFocus.com
Nov-15-18 02:15PM  Managers Of This Fund Like The Outlook For Small-Cap Stocks Investor's Business Daily
Nov-13-18 12:51PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Nov-12-18 09:25AM  BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up Zacks
Nov-09-18 03:28PM  Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat Zacks
Nov-08-18 04:16PM  Endo Plans For Cellulite Drug In 2020 Here's Why Investors Balked Investor's Business Daily -17.72%
12:51PM  Here's Why Endo International Fell as Much as 18.9% Today Motley Fool
12:03PM  Endo International plc (ENDP) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:10AM  Endo targets 2020 for launch of cellulite treatment Reuters
08:30AM  Endo International (ENDP) Q3 Earnings and Revenues Surpass Estimates Zacks
08:25AM  Endo: 3Q Earnings Snapshot Associated Press
07:28AM  Endo stock rises 6% after Q3 beats and upbeat 2018 guidance MarketWatch
07:00AM  Endo Reports Third-Quarter 2018 Financial Results PR Newswire
Nov-07-18 01:30PM  Q3 Earnings Preview For Endo Benzinga -6.48%
10:57AM  Endo posts positive results from experimental cellulite treatment American City Business Journals
07:30AM  Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite PR Newswire
Nov-06-18 10:31AM  What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings? Zacks
Nov-05-18 05:32PM  Endo (ENDP) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-29-18 04:17PM  Knock Offs Loom For J&J's Blockbuster Why An Analyst Is Still Bullish Investor's Business Daily
08:44AM  Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Zacks
Oct-26-18 08:25AM  Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-23-18 08:00AM  Today's Research Reports on Trending Tickers: AbbVie and Endo International ACCESSWIRE
Oct-19-18 08:00AM  Today's Research Reports on Trending Tickers: Endo International and Amarin ACCESSWIRE
Oct-12-18 10:29AM  Rigel (RIGL) Gets EMA Acceptance for Thrombocytopenia Drug Zacks
Oct-11-18 07:30AM  Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting PR Newswire
Oct-09-18 01:04PM  Opioid antidote inventor: We're in the 'next phase of this opioid crisis' Yahoo Finance
Oct-01-18 11:38AM  Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error Zacks
Sep-28-18 02:45PM  Endo to Announce Third-Quarter 2018 Financial Results PR Newswire
11:59AM  [$$] Endo Recalls Robaxin Tablets Due to Dosing Error The Wall Street Journal
09:59AM  Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead Zacks
09:30AM  Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year? Zacks
08:32AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International ACCESSWIRE
08:30AM  Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label PR Newswire
Sep-27-18 08:10AM  Recent Analysis Shows Golar LNG, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, Oracle, Ross Stores, Mellanox Technologies, and Endo International plc Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-24-18 12:11PM  Endo once more agrees to delay FDA litigation American City Business Journals
11:40AM  Endo puts Vasostrict case against U.S. FDA on hold Reuters
06:23AM  Endo puts Vasostrict case against U.S. FDA on hold Reuters
06:00AM  Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End PR Newswire
Sep-18-18 09:35AM  Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
Sep-17-18 08:55AM  The Zacks Analyst Blog Highlights: Ingersoll-Rand, Endo International, Glanbia and Smurfit Kappa Group Zacks
Sep-14-18 10:59AM  5 Problematic Stocks Francis Chou Dared To Buy Insider Monkey
08:03AM  Irish Economy Rebounds in Q2: 4 Great Picks Zacks
Sep-11-18 06:15PM  Goldman's Specialty Pharma Pair Trade: Sidelined On Endo, Bearish On Mallinckrodt Benzinga
11:49AM  Endo advancing experimental cellulite treatment American City Business Journals
Sep-07-18 09:30AM  Endo (ENDP) Up 4.9% Since Last Earnings Report: Can It Continue? Zacks
Sep-06-18 06:51PM  Cramer's lightning round: Anheuser Busch doesn't look attractive because I think we're past beer CNBC
02:20PM  Endo Seeks Separate Settlement to End Opioid Lawsuits Bloomberg
11:02AM  Endo to Participate at Morgan Stanley Global Healthcare Conference PR Newswire
Sep-05-18 04:44PM  Biogen Begins Phase III Study on Ischemic Stroke Candidate Zacks
10:00AM  Here's Why Endo International plc Jumped 37.9% Higher in August Motley Fool
09:43AM  Endo (ENDP) Hits 52-Week High, Can the Run Continue? Zacks
Aug-28-18 12:05PM  Edited Transcript of ENDP earnings conference call or presentation 8-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
10:27AM  Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol Zacks
08:45AM  Ionis Pharmaceuticals (IONS) Looks Good: Stock Adds 7.8% in Session Zacks
Aug-27-18 01:59PM  U.S. FDA proposes restricting compounding of 3 drug substances Reuters
01:56PM  U.S. FDA proposes restricting compounding of 3 drug substances Reuters
12:33PM  U.S. FDA proposes restricting compounding of three drug substances Reuters
09:27AM  Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe Zacks
Aug-21-18 08:15AM  Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting Zacks
Aug-20-18 05:40PM  Buy These 5 Low-Beta Stocks to Brave Market Volatility InvestorPlace
Aug-16-18 01:53PM  Trump administration proposes production quota cuts for six opioids Reuters
Aug-15-18 06:00AM  Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility PR Newswire
Aug-14-18 08:59AM  Amneal Pharmaceuticals (AMRX) Jumps: Stock Rises 5.6% Zacks +5.99%
Aug-11-18 07:03AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Aug-10-18 12:03PM  Endo teaming up with pro golfer for hand disorder awareness campaign American City Business Journals
09:18AM  BioDelivery (BDSI) Q2 Loss Narrows, Sales Miss, Shares Down Zacks
Aug-09-18 10:28AM  Company News For Aug 9, 2018 Zacks
10:26AM  Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance Zacks
08:39AM  The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings Benzinga
07:30AM  PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season PR Newswire
Aug-08-18 04:53PM  Here's Why Endo International Rose as Much as 37.1% Today Motley Fool +28.30%
02:39PM  Endo International plc (ENDP) Q2 2018 Earnings Conference Call Transcript Motley Fool
08:59AM  Implied Volatility Surging for Endo International (ENDP) Stock Options Zacks
08:30AM  Endo International (ENDP) Tops Q2 Earnings and Revenue Estimates Zacks
07:57AM  Endo: 2Q Earnings Snapshot Associated Press
07:29AM  Endo stock soars 13% premarket after Q2 beats, guidance raise MarketWatch
07:07AM  Nevakar and Endo Enter into Exclusive Licensing Agreement for Multiple 505(b)(2) Injectable Products GlobeNewswire
07:00AM  Endo Reports Second-Quarter 2018 Financial Results PR Newswire
07:00AM  Endo International Plc to Host Earnings Call ACCESSWIRE
Aug-07-18 02:52PM  Earnings Preview: Endo International Benzinga
Aug-02-18 06:00PM  U.S. subpoenas AmerisourceBergen over opioid products Reuters
07:30AM  Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs PR Newswire
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals. The U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, abuse-deterrent products, liquids, semi-solids, patches, powders, ophthalmics, sprays, and sterile injectables, as well as products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The U.S. Branded Pharmaceuticals segment provides XIAFLEX for the treatment of Dupuytren's contracture and Peyronie's diseases; SUPPRELIN LA for central precocious puberty treatment; TESTOPEL, a long-acting implantable pellet for the treatment of central precocious puberty; NASCOBAL, a nasal spray to treat vitamin B12 deficiency; and AVEED for the treatment of hypogonadism. This segment also offers pain management products, such as PERCOCET, VOLTAREN Gel, and LIDODERM; TESTIM Gel for the treatment of endogenous testosterone; and FORTESTA Gel for hypogonadism treatment. The International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. It sells its branded pharmaceuticals and generics directly to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MONTAGUE WILLIAM PDirectorDec 10Sale11.4110,000114,10064,888Dec 10 04:07 PM
Hutson Nancy JDirectorNov 15Sale12.8310,000128,30049,970Nov 16 04:03 PM
KIMMEL ROGER HDirectorAug 14Sale15.9014,000222,600120,000Aug 15 04:22 PM
KIMMEL ROGER HDirectorAug 14Sale15.9012,074191,977145,277Aug 15 04:22 PM